Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Aug;36(8):1203-1207.
doi: 10.1016/j.cjca.2020.05.030. Epub 2020 May 28.

Echocardiographic Findings in Patients With COVID-19 Pneumonia

Hani M Mahmoud-Elsayed  1 , William E Moody  2 , William M Bradlow  1 , Ayisha M Khan-Kheil  1 , Jonathan Senior  1 , Lucy E Hudsmith  1 , Richard P Steeds  1
Affiliations
Observational Study

Echocardiographic Findings in Patients With COVID-19 Pneumonia

Hani M Mahmoud-Elsayed et al. Can J Cardiol. 2020 Aug.

Abstract
in English, French

The aim of this study was to characterize the echocardiographic phenotype of patients with COVID-19 pneumonia and its relation to biomarkers. Seventy-four patients (59 ± 13 years old, 78% male) admitted with COVID-19 were included after referral for transthoracic echocardiography as part of routine care. A level 1 British Society of Echocardiography transthoracic echocardiography was used to assess chamber size and function, valvular disease, and likelihood of pulmonary hypertension. The chief abnormalities were right ventricle (RV) dilatation (41%) and RV dysfunction (27%). RV impairment was associated with increased D-dimer and C-reactive protein levels. In contrast, left ventricular function was hyperdynamic or normal in most (89%) patients.

Cette étude visait à caractériser le phénotype échocardiographique des patients atteints de pneumonie causée par la COVID-19 et sa relation avec des biomarqueurs. Soixante-quatorze patients (âgés de 59 ± 13 ans, 78 % de sexe masculin) hospitalisés en raison de la COVID-19 ont participé à l’étude après leur orientation vers le service de cardiologie pour subir une échocardiographie transthoracique dans le cadre des soins courants. Une échocardiographie transthoracique de niveau 1 de la British Society of Echocardiography a été effectuée en vue d’évaluer la taille et la fonction des cavités cardiaques, la valvulopathie et le risque d’hypertension pulmonaire. Les principales anomalies étaient la dilatation du ventricule droit (41 %) et la dysfonction du ventricule droit (27 %). L’atteinte du ventricule droit était associée à une augmentation des taux de D-dimères et de protéines C-réactives. En revanche, la fonction ventriculaire gauche était hyperdynamique ou normale chez la plupart (89 %) des patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship between biomarkers and right ventricular systolic function. Pearson correlation was used for normally distributed data, and Spearman rank correlation for data not normally distributed; a 2-tailed P < 0.05 was considered significant.
See this image and copyright information in PMC

References

    1. Hindocha R., Garry D., Short N. Minimum dataset for a level 1 echocardiogram: a guideline protocol from the British Society of Echocardiography. Echo Res Prac. 2020;7 G51-8. - PMC - PubMed
    1. Lang R.M., Badano L.P., Mor-Avi V. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39.e14. - PubMed
    1. Galiè N., Humbert M., Vachiery J.L. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J. 2016;37:67–119. - PubMed
    1. Tang N., Bai H., Chen X. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094–1099. - PMC - PubMed
    1. Paranjpe I., Fuster V., Lala A. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020;76:122–124. - PMC - PubMed

Publication types

MeSH terms